Avricore Health (AVCRF) Share-based Compensation (2013 - 2024)
Avricore Health (AVCRF) reported Share-based Compensation of $269141.3 for Q3 2024, up 18.56% year-over-year from $227007.5 in Q4 2023, and up 1166.64% quarter-over-quarter from $21248.4 in Q2 2024.
Avricore Health (AVCRF) Share-based Compensation (2013 - 2024) Analysis & Trends
Avricore Health (AVCRF) has 12 years of Share-based Compensation data on file, last reported at $269141.3 in Q3 2024.
- Share-based Compensation for Q3 2024 came in at $269141.3, up 18.56% year-over-year; the trailing twelve-month figure through Sep 2024 was $415637.1 (down 30.33% YoY), and the FY2024 annual result was $395265.9, down 24.21% from the prior year.
- Share-based Compensation rose to $269141.3 in Q3 2024 per AVCRF's latest filing, from $21248.4 in the prior quarter.
- Over five years, Share-based Compensation peaked at $305717.0 in Q1 2021 and troughed at $7113.2 in Q2 2022.
- A 5-year average of $97848.6 and a median of $62226.9 in 2023 frame the typical range for Share-based Compensation.
- On a YoY basis, Share-based Compensation climbed as much as 2361.04% in 2022 and fell as far as 94.55% in 2022.
- A 5-year view of Share-based Compensation shows it stood at $92193.1 in 2020, then tumbled by 92.11% to $7274.1 in 2021, then jumped by 2361.04% to $179018.8 in 2022, then plunged by 41.42% to $104866.0 in 2023, then soared by 156.65% to $269141.3 in 2024.
- Business Quant data shows AVCRF's Share-based Compensation at $269141.3 in Q3 2024, $21248.4 in Q2 2024, and $20381.4 in Q1 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | 20.00 Mn |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | 83.00 Mn |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | 58.00 Mn |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | 16.34 Mn |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | 32.00 Mn |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | 65.00 Mn |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | 95.11 Mn |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | 60.00 Mn |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | 5.47 Mn |
| 10 | Avricore Health | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 269,141.29 |
| Sep 30, 2024 | 269,141.29 |
| Jun 30, 2024 | 21,248.41 |
| Jun 30, 2024 | 21,248.41 |
| Mar 31, 2024 | 20,381.40 |
| Mar 31, 2024 | 20,381.40 |
| Dec 31, 2023 | 104,865.96 |
| Dec 31, 2023 | 104,865.96 |
| Sep 30, 2023 | 227,007.53 |
| Sep 30, 2023 | 227,007.53 |
| Jun 30, 2023 | 125,453.64 |
| Jun 30, 2023 | 125,453.64 |
| Mar 31, 2023 | 65,094.02 |
| Mar 31, 2023 | 65,094.02 |
| Dec 31, 2022 | 179,018.81 |
| Dec 31, 2022 | 179,018.81 |
| Sep 30, 2022 | 44,742.71 |
| Sep 30, 2022 | 44,742.71 |
| Jun 30, 2022 | 7,113.19 |
| Jun 30, 2022 | 7,113.19 |